4basebio PLC (AIM:4BB)
450.00
-35.00 (-7.22%)
May 26, 2026, 4:19 PM GMT
4basebio Balance Sheet
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 17.8 | 34.6 | 3.07 | 4.35 | 9.59 |
Short-Term Investments | - | 0.23 | 0.24 | 0.24 | 0.23 |
Cash & Short-Term Investments | 17.8 | 34.83 | 3.31 | 4.59 | 9.81 |
Cash Growth | -48.88% | 953.83% | -28.01% | -53.22% | -35.52% |
Accounts Receivable | 0.29 | 0.28 | 0.11 | 0.05 | 0.05 |
Other Receivables | - | 1.07 | 1.07 | 0.97 | 0.56 |
Receivables | 0.29 | 1.35 | 1.18 | 1.02 | 0.6 |
Inventory | 0.66 | 0.37 | 0.33 | 0.13 | 0.16 |
Other Current Assets | 1.92 | 0.34 | 0.21 | 0.15 | 0.07 |
Total Current Assets | 20.66 | 36.89 | 5.02 | 5.9 | 10.64 |
Property, Plant & Equipment | 4.03 | 4.33 | 4.2 | 3.63 | 2.76 |
Other Intangible Assets | 4.83 | 1.08 | 0.59 | 0.45 | 0.17 |
Long-Term Deferred Charges | - | 2.4 | 2.08 | 1.67 | 1.1 |
Other Long-Term Assets | 0.03 | 0.03 | 0.03 | 0.04 | 0.03 |
Total Assets | 29.55 | 44.73 | 11.92 | 11.69 | 14.7 |
Accounts Payable | 1.05 | 1.69 | 0.69 | 0.49 | 0.35 |
Accrued Expenses | - | 1.38 | 1.19 | 0.61 | 0.74 |
Current Portion of Long-Term Debt | 0.04 | 0.15 | 0.26 | 0.32 | 0.36 |
Current Portion of Leases | 0.13 | 0.04 | 0.13 | 0.09 | 0.08 |
Other Current Liabilities | 1.61 | - | - | - | - |
Total Current Liabilities | 2.83 | 3.27 | 2.28 | 1.52 | 1.52 |
Long-Term Debt | 15.65 | 14.29 | 9.3 | 2.41 | 0.86 |
Long-Term Leases | 0.69 | 0.73 | 0.76 | 0.52 | 0.47 |
Long-Term Unearned Revenue | 0.27 | 0.05 | 0.07 | 0.12 | 0.16 |
Total Liabilities | 19.44 | 18.35 | 12.41 | 4.57 | 3.01 |
Common Stock | 13.8 | 13.77 | 11.13 | 11.13 | 11.13 |
Additional Paid-In Capital | 37.25 | 37.25 | 0.71 | 0.71 | 0.71 |
Retained Earnings | -55.63 | -38.72 | -26.39 | -18.73 | -13.58 |
Comprehensive Income & Other | 14.68 | 14.08 | 14.06 | 14.01 | 13.43 |
Shareholders' Equity | 10.11 | 26.38 | -0.49 | 7.12 | 11.7 |
Total Liabilities & Equity | 29.55 | 44.73 | 11.92 | 11.69 | 14.7 |
Total Debt | 16.51 | 15.22 | 10.46 | 3.35 | 1.76 |
Net Cash (Debt) | 1.3 | 19.61 | -7.15 | 1.24 | 8.06 |
Net Cash Growth | -93.38% | - | - | -84.59% | -40.34% |
Net Cash Per Share | 0.08 | 1.50 | -0.58 | 0.10 | 0.65 |
Filing Date Shares Outstanding | 15.53 | 15.48 | 12.32 | 12.32 | 12.32 |
Total Common Shares Outstanding | 15.53 | 15.48 | 12.32 | 12.32 | 12.32 |
Working Capital | 17.84 | 33.62 | 2.75 | 4.38 | 9.12 |
Book Value Per Share | 0.65 | 1.70 | -0.04 | 0.58 | 0.95 |
Tangible Book Value | 5.29 | 25.3 | -1.08 | 6.67 | 11.53 |
Tangible Book Value Per Share | 0.34 | 1.63 | -0.09 | 0.54 | 0.94 |
Land | - | 1.04 | 1.04 | 1.04 | 1 |
Machinery | - | 4.58 | 3.67 | 2.8 | 0.88 |
Construction In Progress | - | - | - | - | 0.75 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.